Human sulfatases: A structural perspective to catalysis

Cellular and Molecular Life Sciences

Volumn 64, Issue 15, 2007, Pages 2013-2022

  Ghosh, D ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Aryl sulfatase; Catalysis; Crystal structure; Estrone sulfate; Membrane protein; Steroid sulfatase; Sulfatase; Three dimensional structure

Indexed keywords

ARYLSULFATASE; CYSTEINE; ESTRONE; ESTRONE SULFATE; FORMYLGLYCINE; GLYCINE DERIVATIVE; MEMBRANE PROTEIN; STERYL SULFATASE; SULFATASE; SULFATE; UNCLASSIFIED DRUG; WATER;

AMINO ACID SEQUENCE; BINDING SITE; BREAST CANCER; CATALYSIS; CRYSTAL STRUCTURE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; EUKARYOTIC CELL; GENETIC DISORDER; GENETIC IDENTIFICATION; HORMONAL CARCINOGENESIS; HUMAN; HYDROLYSIS; HYDROPHOBICITY; HYDROXYLATION; LIPID BILAYER; METAL BINDING; PROKARYOTIC CELL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY; SOLUBILITY;

AMINO ACIDS; BREAST NEOPLASMS; CATALYSIS; CATALYTIC DOMAIN; CEREBROSIDE-SULFATASE; CRYSTALLOGRAPHY, X-RAY; ELECTROSTATICS; FEMALE; HUMANS; MALE; MODELS, MOLECULAR; N-ACETYLGALACTOSAMINE-4-SULFATASE; PREGNANCY; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; STERYL-SULFATASE; SULFATASES;

EUKARYOTA; PROKARYOTA;

EID: 34447618279     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7175-y     Document Type: Review

References (59)

1. Parenti,G., Germana,M. and Ballabio,A. (1997) The sulfatase gene family. Curr. Opin. Genet. Dev. 7, 386-391.
2. Diez-Roux,G. and Ballabio, A. (2005) Sulfatases and human diseases. Annu. Rev. Genomics Hum. Genet. 6, 355-379.
3. Schmidt, B., Selmer, T., Ingendoh, A. and von Figura, K. (1995) A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 82, 271-278.
4. Recksiek, M., Selmer, T., Dierks, T., Schmidt, B. and von Figura, K. (1998) Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine. J. Biol. Chem. 273, 6096-6103.
5. Neufeld, E. F. and Muenzer, J. (2001) The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease, 8th edn, vol. 3, pp. 3421-3452, Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W. and Vogelstein, B. (eds.), McGraw-Hill, New York.
6. Vaccaro, A. M., Salvioli, R., Muscillo, M. and Renola, L. (1987) Purification and properties of arylsulfatase C from human placenta. Enzyme 37, 115-126.
7. Hernandez-Guzman, F. G., Higashiyama, T., Osawa, Y. and Ghosh, D. (2001) Purification, characterization and crystallization of human placental estrone/dehydroepiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum. J. Steroid Biochem. Mol. Biol. 78, 441-450.
8. Hernandez-Guzman, F. G., Higashiyama, T., Pangborn, W., Osawa, Y. and Ghosh, D. (2003) Structure of human estrone sulfatase suggests functional roles of membrane association. J. Biol. Chem. 278, 22989-22997.
9. Noel, H., Plante, L., Bleau, G., Chapdelaine, A. and Roberts, K. D. (1983) Human placental steroid sulfatase: Purification and properties. J. Steroid Biochem. 19, 1591-1598.
10. Dibbelt, L. and Kuss, E. (1986) Human placental sterylsulfatase: Enzyme purification, production of antisera, and immunoblotting reactions with normal and sulfatase-deficient placentas, Biol. Chem. Hoppe-Seyler 367, 1223-1229.
11. Burns, G. R. J. (1983) Purification and partial characterization of arylsulphatase C from human placental microsomes. Biochim. Biophys. Acta 759, 199-204.
12. Yanaihara, A., Yanaihara, T., Toma, Y., Shimizu, Y., Saito, H., Okai, T., Higashiyama, T. and Osawa, Y. (2001) Localization and expression of steroid sulfatase in human fallopian tube. Steroids 66, 87-91.
13. Stein, C., Hille, A., Seidel, J., Rijnbout, S., Waheed, A., Schmidt, B., Gueze, H. and von Figura, K. (1987). Cloning and expression of human steroid sulfatase. J. Biol. Chem. 264, 13865-13872.
14. Suzuki, T., Hirato, K., Yanaihara, T., Kodofuku, T., Sato, T., Hoshino, M. and Yanaihara, N. (1992) Purification and properties of steroid sulfatase from human placenta. Endocrinol. Jpn. 39, 93-101.
15. Van der Loos, C. M., Van Breda, A. J., Van den Berg, F. M., Walboomers, J. M. M. and Jobsis, A.C. (1983) Human placental steroid sulfatase purification and monospecific antibody production in rabbits. J. Inherit. Metab. Dis. 7, 97-103.
16. Purohit, A., Potter, B. V. L., Parker, M. G. and Reed, M. J. (1998) Steroid sulfatase: expression, isolation and inhibition for active site identification studies. Chem. Biol. Interact. 109, 183-193.
17. Alperin, E. S. and Shapiro, L. J. (1997) Characterization of point mutations in patients with X-linked ichthyosis. J. Biol. Chem. 272, 20756-20763.
18. Hernandez-Martin, A., Gonzalez-Sarmiento, R. and De Unamuno, P. (1999) X-linked ichthyosis: an update. Br. J. Dermatol. 141, 617-627.
19. Ghosh, D. (2004) Mutations in X-linked ichthyosis disrupt the active site structure of Estrone/DHEA sulfatase. Biochim. Biophys. Acta 1739, 1-4.
20. Uchimura, K., Morimoto-Tomita, M. and Rosen, S. D. (2006) Measuring the activities of the Sulfs: two novel heparin/heparan sulfate endosulfatases. Methods Enzymol. 416, 243-253.
21. Cosma, M. P., Pepe, S., Annunziata, I., Newbold, R. F., Grompe, M., Parenti, G. and Ballabio, A. (2003) The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 113, 445-456.
22. Dierks, T., Dickmanns, A., Preusser-Kunze, A., Schmidt, B., Mariappan, M., von Figura, K., Ficner, R. and Rudolph, M. G. (2005) Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme. Cell 121, 541-552.
23. Dierks, T., Schmidt, B., Borissenko, L. V., Peng, J., Preusser, A., Mariappan, M. and von Figura, K. (2003) Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 113, 435-444.
24. Lukatela, G., Krauss, N., Theis, K., Selmer, T., Gieselmann, V., von Figura, K. and Saenger, W. (1998) Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37, 3654-3664.
25. Bond, C. S., Clements, P. R., Ashby, S. J., Collyer, C. A., Harrop, S. J., Hopwood, J. J. and Guss, J.M. (1997) Structure of human lysosomal sulfatase. Structure 5, 277-289.
26. Boltes, I., Czapinska, H., Kahnert, A., von Bülow, R., Dierks, T., Schmidt, B., von Figura, K., Kertesz, M. A. and Usón, I. (2001) 1.3 Å structure of arylsulfatase from P. aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family. Structure 9, 483-491.
27. Pasqualini, J. R. and Chetrite, G. S. (2002) The selective estrogen enzyme modulators in breast cancer. In: Breast Cancer. Prognosis, Treatment and Prevention, pp. 187-249, Pasqualini, J. R. (ed.), Marcel Dekker, New York.
28. Reed, M. J. and Purohit, A. (1997) Breast cancer and the role of cytokines in the regulating estrogen synthesis: an emerging hypothesis. Endocr. Rev. 18, 701-715.
29. Billich, A., Nussbaumer, P. and Lehr, P. (2000) Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel nonsteroidal steroid sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 73, 225-235.
30. Suzuki, T., Nakata, T., Miki, Y., Kaneko, C., Moriya, T., Ishida, T., Akinaga, S., Hirakawa, H., Kimura, M. and Sasano, H. (2003) Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res. 63, 2762-2770.
31. Miyoshi, Y., Ando, A., Hasegawa, S., Ishitobi, M., Taguchi, T., Tamaki, Y. and Noguchi, S. (2003) High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancers. Clin. Cancer Res. 9, 2288-2293.
32. Selcer, K.W., Kabler, H., Saraf, J., Xiao, Z. and Li, P.-K. (2002) Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. Steroids 67, 821-826.
33. Dalla Valle, L., Toffolo, V., Nardi, A., Fiore, C., Bernante, P., Di Liddo, R., Parnigotto, P. P. and Colombo, L. (2006) Tissue specific transcriptional inhibition and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activation in human adipose tissue. J. Endocrinol. 190, 129-139.
34. Utsunomiya, H., Ito, K., Suzuki, T., Kitamura, T., Kaneko, C., Nakata, T., Niikura, H., Okamura, K., Yaegashi, N. and Sasano, H. (2004) Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin. Cancer Res. 10, 5850-5856.
35. Al Sarakbi, W., Mokbel, R., Salhab, M., Jiang, W. G., Reed, M. J. and Mokbel, K. (2006) The role of STS and OATP-B mRNA expression in predicting clinical outcome in human breast cancer. Anticancer Res. 26, 4985-4990.
36. Nakamura, Y., Suzuki, T., Fukuda, T., Ito, A., Endo, M., Moriya, T., Arai, Y. and Sasano, H. (2006) Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate 66, 1005-1012.
37. von Bulow, R., Schmidt, B., Dierks, T., von Figura, K. and Uson, I. (2001) Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. J. Mol. Biol. 305, 269-277.
38. Chruszcz, M., Laidler, P., Monkiewicz, M., Ortlund, E., Lebioda, L. and Lewinski, K. (2003) Crystal structure of a covalent intermediate of endogenous human arylsulfatase A. J. Inorg. Biochem. 96, 386-392.
39. Fleming, S.M., Robertson, T. A., Langley, G. J. and Bugg, T.D. H. (2000) Catalytic mechanism of a C-C hydrolase enzyme: evidence for a gem-diol intermediate, not an acyl enzyme. Biochemistry 39, 1522-1531.
40. 13C NMR spectroscopy. Biochemistry 45, 12461-12469.
41. Ghosh, D. (2005) Three-dimensional structures of sulfatases. Methods Enzymol. 400, 273-293.
42. Ghosh, D. and Vihko, P. (2002) Molecular mechanism of estrogen recognition and 17-keto reduction by 17β-hydroxysteroid dehydrogenase type 1. Chem. Biol. Interact. 130-132, 637-650.
43. +. Proc. Natl. Acad. Sci. USA 96, 840-845.
44. Nussbaumer, P. and Billich, A. (2004) Steroid sulfatase inhibitors. Med. Res. Rev. 24, 529-576.
45. Reed, M. J., Purohit, A., Woo, L. W., Newman, S. P. and Potter, B. V. (2005) Steroid sulfatase: molecular biology, regulation and inhibition. Endocr. Rev. 26, 171-202.
46. Purohit, A., Potter, B. V. L., Williams, G. J., Howarth, N. M., Potter, B. V. and Reed, M. J. (1995) Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34, 11508-11514.
47. Woo, L. W. L., Purohit, A., Malini, B., Reed, M. J. and Potter, B. V. L. (2000) Potent active site-directed inhibition of steroid sulfatase by tricyclic coumarin-based sulfamates. Chem. Biol. 7, 773-791.
48. Nussbaumer, P., Lehr, P. and Billich, A. (2002) 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J. Med. Chem. 45, 4310-4320.
49. Stanway, S. J., Purohit, A., Woo, L. W., Sufi, S., Vigushin, D., Ward, R., Wilson, R. H., Stanczyk, F. Z., Dobbs, N., Kulinskaya, E., Elliott, M., Potter, B. V., Reed, M. J. and Coombes, R. C. (2006) Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin. Cancer Res. 12, 1585-1592.
50. Lapierre, J., Ahmed, V., Chen, M.-J., Ispahany, I., Guillemette, J. G. and Taylor, S. D. (2004) The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: A new approach to steroid sulfatase inhibitors. Bioorg. Med. Chem. Lett. 14, 151-155.
51. Liu, Y., Ahmed, V., Hill, B. and Taylor, S. D. (2005) Synthesis of a non-hydrolyzable estrone sulfate analogue bearing the difluoromethanesulfonamide group and its evaluation as a steriod sulfatase inhibitor. Org. Biomol. Chem. 3, 3329-3335.
52. Ahmad, V., Liu, Y., Silvestro, C. and Taylor, S. D. (2006) Boronic acids as inhibitors of steroid sulfatase. Bioorg. Med. Chem. 14, 8564-8573.
53. Poirier, D. and Boivin, R. P. (1998) 17alpha-alkyl- or 17alpha-substituted-17beta-estradiols. A new family of estrone-sulfatase inhibitors. Bioorg. Med. Chem. Lett. 8, 1891-1896.
54. Boivin, R. P., Luu-The, V., Lachance, R., Labrie, F. and Poirier, D. (2000) Structure-activity relationships of 17-alpha derivatives of estradiol as inhibitors of steroid sulfatase. J. Med. Chem. 43, 4465-4478.
55. Ishida, H., Nakata, T., Suzuki, M., Shiotsu, Y., Tanaka, H., Sato, N., Terasaki, Y., Takebayashi, M., Anazawa, H., Murakata, C., Li, P. K., Kuwabara, T. and Akinaga, S. (2007) A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models. Breast Cancer Res. Treat. (Epub ahead of print).
56. Foster, P.A., Newman, S. P., Chander, S. K., Stengel, C., Jhalli, R., Woo, L. L., Potter, B.V., Reed, M. J. and Purohit, A. (2006). In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy. Clin. Cancer Res. 12, 5543 - 5549.
57. Rasmussen, L. M., Zaveri, N. T., Stenvang, J., Peters, R.H. and Lykkesfeldt, A. E. (2007) A novel dual-target steroid sulfatase inhibitor and anti-estrogen: SR 16157, a promising agent for the therapy of breast cancer. Breast Cancer Res. Treat. (Epub ahead of print).
58. Numazawa, M., Tominaga, T., Watari, Y. and Tada, Y. (2006) Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen-3-sulfamates. Steroids 71, 371 - 379.
59. Hopwood, J. J., Bate, G. and Kirkpatrick, P. (2006) Galsulfatase. Nat. Rev. Drug Discov. 5, 101.